← FDA Drug Approvals (Drugs@FDA)

DAXXIFY

BLA · Biologics License Application · Sponsor: REVANCE THERAPEUTICS, INC. · Approved 2022-09-07

Drug application

FDA Application #

BLA761127

Application type

Biologics License Application

Brand name

DAXXIFY

Generic name

BOTULINUM TOXIN TYPE A

Active ingredients

DAXIBOTULINUMTOXINA-LANM

Dosage form

INJECTABLE

Route

INTRAMUSCULAR, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

REVANCE THERAPEUTICS, INC.

Manufacturer

Revance Therapeutics, Inc.

First approval

2022-09-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown